BIOMAT Database Logo BIOMAT Database Logo

Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children. A randomized, double-blind study. 1990

L Brendstrup, and K Hjelt, and K E Petersen, and S Petersen, and E A Andersen, and P S Daugbjerg, and B R Stagegaard, and O H Nielsen, and R Vejlsgaard, and G Schou
Department of Paediatrics, Hillerød Hospital, University of Copenhagen, Denmark.

The efficiency of nitrofurantoin and trimethoprim prophylaxis in preventing recurrent urinary tract infections (UTI) was compared by means of actuarial percentage recurrence-free curves in a randomized, double blind study in 130 children (126 girls, 4 boys) aged 1 to 14 years (mean 7.5). The children received the antibiotics for 6 months. Nitrofurantoin proved to be the most efficient prophylactic drug in patients with abnormal urography and/or reflux (n = 60) as evaluated by actuarial percentage recurrence-free analysis (p = 0.0025). However, no differences was found in patients without urinary tract abnormalities. Nitrofurantoin prophylaxis altered neither the pattern of resistance nor the bacteriological constellation, while patients receiving trimethoprim prophylaxis had 76% trimethoprim resistant bacteria during prophylaxis, compared with 8% before (p less than 0.0001) and 17% after (p less than 0.0001) prophylaxis. The percentage of recurrences due to E. coli (70-80%) was unaffected by trimethoprim prophylaxis, but the proportion due to trimethoprim resistant E. coli was significantly higher during prophylaxis (65%) than before (6%, p less than 0.0001) and after (11%, p less than 0.001). The percentage of Staphylococcus epidermidis UTI was significantly higher during trimethoprim prophylaxis (27%) than before (2%, p less than 0.0003). Following prophylaxis there was no difference in the actuarial percentage recurrence-free curves of the two regimens. Side effects occurred more frequently in the nitrofurantoin group (37%) than in the trimethoprim group (21%) (p = 0.05). The majority of side effects in the nitrofurantoin group derived from gastrointestinal symptoms. In conclusion, nitrofurantoin is recommended as the first choice prophylactic treatment of children with recurrent UTI and urinary tract abnormalities.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D009582 Nitrofurantoin A urinary anti-infective agent effective against most gram-positive and gram-negative organisms. Although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression. Furadantin,Furadantine,Furadoine,Furadonine,Furantoin,Macrodantin,Nitrofurantoin Sodium Salt,Nitrofurantoin, Monohydrate
D010349 Patient Compliance Voluntary cooperation of the patient in following a prescribed regimen. Client Adherence,Client Compliance,Non-Adherent Patient,Patient Adherence,Patient Cooperation,Patient Noncompliance,Patient Non-Adherence,Patient Non-Compliance,Patient Nonadherence,Therapeutic Compliance,Treatment Compliance,Adherence, Client,Adherence, Patient,Client Compliances,Compliance, Client,Compliance, Patient,Compliance, Therapeutic,Compliance, Treatment,Cooperation, Patient,Non Adherent Patient,Non-Adherence, Patient,Non-Adherent Patients,Non-Compliance, Patient,Nonadherence, Patient,Noncompliance, Patient,Patient Non Adherence,Patient Non Compliance,Patient, Non-Adherent,Therapeutic Compliances,Treatment Compliances
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females

Related Publications

L Brendstrup, and K Hjelt, and K E Petersen, and S Petersen, and E A Andersen, and P S Daugbjerg, and B R Stagegaard, and O H Nielsen, and R Vejlsgaard, and G Schou
Nitrofurantoin versus trimethoprim for low-dose long-term prophylaxis in patients with recurrent urinary tract infections. A prospective randomized study.
January 1992, International urology and nephrology,
L Brendstrup, and K Hjelt, and K E Petersen, and S Petersen, and E A Andersen, and P S Daugbjerg, and B R Stagegaard, and O H Nielsen, and R Vejlsgaard, and G Schou
Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial.
August 1990, JAMA,
L Brendstrup, and K Hjelt, and K E Petersen, and S Petersen, and E A Andersen, and P S Daugbjerg, and B R Stagegaard, and O H Nielsen, and R Vejlsgaard, and G Schou
Long-term prophylaxis with norfloxacin versus nitrofurantoin in women with recurrent urinary tract infection.
June 1991, Antimicrobial agents and chemotherapy,
L Brendstrup, and K Hjelt, and K E Petersen, and S Petersen, and E A Andersen, and P S Daugbjerg, and B R Stagegaard, and O H Nielsen, and R Vejlsgaard, and G Schou
Prophylaxis for recurrent urinary tract infections: nitrofurantoin, not trimethoprim-sulfamethoxazole or cranberry juice.
January 2012, Archives of internal medicine,
L Brendstrup, and K Hjelt, and K E Petersen, and S Petersen, and E A Andersen, and P S Daugbjerg, and B R Stagegaard, and O H Nielsen, and R Vejlsgaard, and G Schou
Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole.
June 1975, Canadian Medical Association journal,
L Brendstrup, and K Hjelt, and K E Petersen, and S Petersen, and E A Andersen, and P S Daugbjerg, and B R Stagegaard, and O H Nielsen, and R Vejlsgaard, and G Schou
Trimethoprim-sulfamethoxazole in recurrent urinary tract infection in children.
November 1973, The Journal of infectious diseases,
L Brendstrup, and K Hjelt, and K E Petersen, and S Petersen, and E A Andersen, and P S Daugbjerg, and B R Stagegaard, and O H Nielsen, and R Vejlsgaard, and G Schou
Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole.
August 1993, The American journal of medicine,
L Brendstrup, and K Hjelt, and K E Petersen, and S Petersen, and E A Andersen, and P S Daugbjerg, and B R Stagegaard, and O H Nielsen, and R Vejlsgaard, and G Schou
The treatment of urinary tract infections in out-patients A double-blind comparison between trimethoprim and nitrofurantoin.
January 1981, The Journal of international medical research,
L Brendstrup, and K Hjelt, and K E Petersen, and S Petersen, and E A Andersen, and P S Daugbjerg, and B R Stagegaard, and O H Nielsen, and R Vejlsgaard, and G Schou
Use of nitrofurantoin in chronic and recurrent urinary tract infection in children.
February 1959, Journal of the American Medical Association,
L Brendstrup, and K Hjelt, and K E Petersen, and S Petersen, and E A Andersen, and P S Daugbjerg, and B R Stagegaard, and O H Nielsen, and R Vejlsgaard, and G Schou
Antibiotic prophylaxis and recurrent urinary tract infection in children.
February 2010, The New England journal of medicine,
Copied contents to your clipboard!